- just a reminder
16/9/20 from hottod
Avecho
The following information describing AVE’s TPM injectables products has been condensed from two presentations, which were released in December 2019 and June this year.
TPM®/Daptomycin
- Daptomycin is supplied as a lyophilized powder for reconstitution
- TPM increases daptomycin solubility, allowing reconstitution in < 5 minutes to significantly increase workflow efficiency in the hospital
- Daptomycin shelf-life stability increased to 24 hours at RT, and 72 hours in fridge.
- Longer stability also enables larger, multi-use vials and provides commercial supply chain advantage
TPM®/Propofol
- TPM creates a transparent and thermodynamically stable microemulsion
- No egg or soy based excipients, no risk of anaphylaxis, and reduced risk for bacterial growth
- Clear formulation (better presentation) allows QC and confidence during infusion / mixture – less chance of product recall
- Simple manufacture method; COGS projected to be cheaper than standard propofol emulsion
- TPM® would significantly reduce the risk and expense of the supply chain for propofol
- Could grow the overall propofol market, which has suffered from manufacturing issues and resulting product shortages
TPM®/Vitamin K
- TPM dissolves the Vitamin K in a stable, colloidal vesicle system
- TPM formulations of Vitamin K developed which are: - free of problematic excipients (Cremaphor, Polysorbate 80, Lecithin) - stable for 2yrs - suitable for dosing paediatric (2mg/ml) and adult (10mg/ml) patients
- There are no known allergens in the product, and no anticipated safety concerns.
TPM®/Tacrolimus
- TPM/Tacrolimus formulations made without Cremaphor (known adverse excipient)
- TPM solubilizes tacrolimus during dilution prior to infusion
TPM®/Melphalan
- Melpahan is a water insoluble powdered (lyophilized) drug dissolved prior to use
- There are no commercially available liquid formulations that would reduce handling prior to administration.
- Liquid TPM/melphalan formulations successfully created
TPM®/Clopidogrel
- Clopidogrel is a powder given as an oral tablet for stroke.
- An immediate, injectable alternative dosage format would be advantageous for stroke patients, but clopidogrel is insoluble at the typical pH range of IV injections (pH 3-10).
- Liquid TPM/clopidogrel formulations suitable for injection successfully created
- Forums
- ASX - By Stock
- AVE
- Ann: Chair's Address and CEO Presentation
Ann: Chair's Address and CEO Presentation, page-7
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 36084472 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 35403846 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 35884472 | 0.002 |
16 | 47966742 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 34903846 | 20 |
0.004 | 27247196 | 14 |
0.005 | 8100000 | 7 |
0.006 | 8723435 | 8 |
0.007 | 13229103 | 6 |
Last trade - 16.12pm 11/10/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
Day chart unavailable